Meet EQRX, a startup that just raised $200 million to take on Big Pharma by making drugs cheaper
01/12/2020 General World News
Doctor in medical lab.

  • Meet EQRX, a company that’s developing new drugs it plans to charge less for that’ll compete for some of the highest priced drugs on the market.
  • The startup just raised $200 million from investors including GV, ARCH Venture Partners, and Andreessen Horowitz.
  • CEO Alexis Borisy told Business Insider he’s aiming to get the startup’s first drug approved in 5 years, with the goal of having 10 approved in the company’s first decade.
  • Subscribe to Dispensed, Business Insider’s weekly healthcare newsletter.
  • Click here for more BI Prime stories.

A new startup just launched that plans to take an unusual approach read more >>>

Source:: BusinessInsider.Com

Comments are closed
BusinessMediaguide.Com Independent, Global Business Media Network © 2020. ALL RIGHTS RESERVED. BusinessMediaguide.Com is not responsible for the content of external sites!... Beta...

Privacy policy